Ismail Tarkhan
Internal Medicine · Milford, CTNPI 1902848609
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 396 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $5,458 and has fallen 97.9% since, to $113 in 2023. Among internal medicine clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 396 payments — averaging $30.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Boehringer Ingelheim$2K
- Novo Nordisk$1K
- Merck$1K
- GSK$946
- Amgen$905
- plus $4K from 18 others
Across 17 payments — averaging $996.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$17K
What the payments were for
- Food & beverage$11,898100%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 58 | $2,482 |
| Boehringer Ingelheim | 31 | $1,606 |
| Novo Nordisk | 42 | $1,208 |
| Merck | 39 | $1,067 |
| GSK | 32 | $946 |
| Amgen | 35 | $905 |
| Lilly USA, LLC | 32 | $734 |
| Amarin Pharma, Inc. | 29 | $614 |
| Novartis | 19 | $436 |
| Arbor Pharmaceuticals, Inc. | 34 | $397 |
| AbbVie(2 entities) | 12 | $331 |
| Sanofi | 2 | $250 |
| Medtronic(2 entities) | 2 | $222 |
| Sanofi-aventis U.S. LLC | 7 | $141 |
| Johnson & Johnson | 2 | $139 |
| Bayer | 1 | $125 |
| Currax Pharmaceuticals LLC | 7 | $114 |
| Pfizer | 3 | $61 |
| Mylan Specialty L.p. | 2 | $47 |
| Eisai Inc. | 3 | $37 |
| Indivior Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Nalpropion Pharmaceuticals LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,924 in reported general payments places this provider in the 95th percentile of 2,067 internal medicine providers in Connecticut.
Other internal medicine in Milford
- Steven SaundersMilford$49K
- Gary SpectorMilford$32K
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$1.6M
- Arthur DecillisMadison$1M
- Charles MontanoCromwell$970K
- Gary BlickNorwalk$683K
- Scott GottliebStamford$508K
- Jeffrey KatzOxford$361K
- Nicholas DainiakBridgeport$352K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.